+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
From
Vitiligo - Pipeline Insight, 2025 - Product Thumbnail Image

Vitiligo - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Spasticity - Pipeline Insight, 2025 - Product Thumbnail Image

Spasticity - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Pyelonephritis - Pipeline Insight, 2025 - Product Thumbnail Image

Pyelonephritis - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Peanut Allergy - Pipeline Insight, 2025 - Product Thumbnail Image

Peanut Allergy - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Aplastic Anemia - Pipeline Insight, 2025 - Product Thumbnail Image

Aplastic Anemia - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Eosinophilic Esophagitis - Pipeline Insight, 2025 - Product Thumbnail Image

Eosinophilic Esophagitis - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Myopia - Pipeline Insight, 2025 - Product Thumbnail Image

Myopia - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Nasal Polyps - Pipeline Insight, 2025 - Product Thumbnail Image

Nasal Polyps - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Atrial Fibrillation - Pipeline Insight, 2025 - Product Thumbnail Image

Atrial Fibrillation - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Focal Segmental Glomerulosclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Focal Segmental Glomerulosclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Sjogren's Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Sjogren's Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Chronic Spontaneous Urticaria - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Spontaneous Urticaria - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Complicated Urinary Tract Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Complicated Urinary Tract Infections - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Facioscapulohumeral Muscular Dystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Facioscapulohumeral Muscular Dystrophy - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
Pneumococcal Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Pneumococcal Disease - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Acute Ischemic Stroke - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Ischemic Stroke - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Sodium Channel Blockers - Pipeline Insight, 2025 - Product Thumbnail Image

Sodium Channel Blockers - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 180 Pages
  • Global
From
Graves' Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Graves' Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more